DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ezetimibe

Ezetimibe

  • Ezetimibe: a Novel Selective Cholesterol Absorption Inhibitor by Michele Koder, Pharm.D

    Ezetimibe: a Novel Selective Cholesterol Absorption Inhibitor by Michele Koder, Pharm.D

  • Fenofibrate Ezetimibe Studies

    Fenofibrate Ezetimibe Studies

  • SUMMARY of the PRODUCT CHARACTERISTICS 1. NAME of the MEDICINAL PRODUCT <Invented Name> 10 Mg/10 Mg Film-Coated Tablets

    SUMMARY of the PRODUCT CHARACTERISTICS 1. NAME of the MEDICINAL PRODUCT <Invented Name> 10 Mg/10 Mg Film-Coated Tablets

  • Zetia® (Ezetimibe) Tablets

    Zetia® (Ezetimibe) Tablets

  • Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe Vs

    Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe Vs

  • CP.PMN.237 Bempedoic Acid (Nexletol)

    CP.PMN.237 Bempedoic Acid (Nexletol)

  • Information for the User Ezetimibe/Simvastatin Clonmel 10 Mg/10 Mg Tablets Ezetimibe/Simvastatin Clonmel 10 Mg

    Information for the User Ezetimibe/Simvastatin Clonmel 10 Mg/10 Mg Tablets Ezetimibe/Simvastatin Clonmel 10 Mg

  • 10 Mg/80 Mg Filmtabletten

    10 Mg/80 Mg Filmtabletten

  • Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL

    Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL

  • Efficacy and Safety of Triplet Therapy With

    Efficacy and Safety of Triplet Therapy With

  • Zetia® (Ezetimibe) Tablets

    Zetia® (Ezetimibe) Tablets

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Report on the Deliberation Results February 26, 2019 Pharmaceutical

    Report on the Deliberation Results February 26, 2019 Pharmaceutical

  • INTEGRATED REVIEW Executive Summary Interdisciplinary Assessment Appendices NDA211617 Nexlizet I Bempedoic Acid and Ezetimibe

    INTEGRATED REVIEW Executive Summary Interdisciplinary Assessment Appendices NDA211617 Nexlizet I Bempedoic Acid and Ezetimibe

  • Lipotropics, Other

    Lipotropics, Other

  • ZETIA® (Ezetimibe) Tablets Liver Enzyme Abnormalities and Monitoring: Persistent Elevations in Initial U.S

    ZETIA® (Ezetimibe) Tablets Liver Enzyme Abnormalities and Monitoring: Persistent Elevations in Initial U.S

  • Prescribing Information

    Prescribing Information

  • Australian Public Assessment Report for Ezetimibe and Atorvastatin

    Australian Public Assessment Report for Ezetimibe and Atorvastatin

Top View
  • ZETIA® (Ezetimibe) Tablets
  • Australian Public Assessment Report for Pitavastatin
  • Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Normalizes Combined Dyslipidemia in Obese Hyperinsulinemic Hamsters Margaret Van Heek, Theodore M
  • ROSZET (Rosuvastatin and Ezetimibe) Tablets, for Oral Use Occurred, Some Persistent
  • And Bempedoic Acid/Ezetimibe (Nexlizet™) New Drug Update
  • V010 Package Leaflet: Information for the Patient Ezetimibe/Simvastatin 10 Mg/10 Mg, 10 Mg/20 Mg, 10 Mg/40 Mg, 10 Mg/80 Mg Table
  • (Ezetimibe/Simvastatin) Tablets Patient Information About VYTORIN
  • Zetia® (Ezetimibe) Tablets
  • Product Monograph
  • EZETIMIBE/ATORVASTATIN GH Ezetimibe and Atorvastatin (As Calcium Trihydrate)) Tablets
  • TRICOR® 48 Mg and 145 Mg (Fenofibrate Tablets)
  • Clinical Policy: Ezetimibe/Simvastatin (Vytorin) 10/80 Mg Reference Number
  • Product Monograph
  • LIPID LOWERING THERAPIES Llorente Serrano M, Sánchez Gundín J, Rueda Naharro A, Martí Gil C, Martínez Valdivieso L, Barreda Hernández D
  • Accessibility Improving Information Using Online Patient Drug Reviews
  • Clinical Policy: Ezetimibie and Simvastatin (Vytorin)
  • For Peer Review Only Journal: BMJ Open
  • VYTORIN (Ezetimibe/Simvastatin)


© 2024 Docslib.org    Feedback